Rivaroxaban tablets are anticoagulant drugs that are mainly used to prevent the formation of venous thrombosis and pulmonary embolism. The duration of treatment, safety and efficacy are excellent, and the likelihood of rivaroxaban tablets causing bleeding is very low.
Rivaroxaban Tablet is a highly selective oral anticoagulant with the effect of inhibiting coagulation. It is indicated for the prevention of venous thrombosis and pulmonary embolism after hip or knee replacement surgery, and also for the treatment of atrial fibrillation.
Rivaroxaban Tablet may cause occult or overt bleeding conditions in some tissues and organs. Hypersensitivity to rivaroxaban tablets, significant active bleeding, coagulation abnormalities, hematologic disorders, hepatic or renal insufficiency, pregnant as well as lactating women are contraindicated.
The specific dosage of rivaroxaban must be taken under the guidance of the doctor as prescribed by the doctor, to avoid the adverse effects of private medication.